Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Neuro-Oncology Advances|May 8, 2023
A single-institution retrospective analysis of pathologically determined malignant transformation in <i>IDH</i> mutant glioma patientsVicki Liu, Ethan A Wetzel, Blaine S C Eldred, et al.
Journal of Neuro-Oncology|February 27, 2019
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastomaJingwen Yao, Caleb Hock Pang Tan, Jacob Schlossman, et al.
Neuro-Oncology|May 29, 2024
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumorsNicholas S Cho, Viên Lam Le, Francesco Sanvito, et al.
Neuroradiology|October 27, 2020
Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomasTalia C Oughourlian, Jingwen Yao, Akifumi Hagiwara, et al.
Molecular Imaging and Biology|December 4, 2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant GliomasElena Karavaeva, Robert J Harris, Kevin Leu, et al.
Journal of Neuro-Oncology|March 12, 2026
MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapyTerry J Prins, Thomas J Lai, Tie Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
European Radiology|October 26, 2023
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRIFrancesco Sanvito, Catalina Raymond, Nicholas S Cho, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Neuro-Oncology Advances|May 8, 2023
A single-institution retrospective analysis of pathologically determined malignant transformation in <i>IDH</i> mutant glioma patientsVicki Liu, Ethan A Wetzel, Blaine S C Eldred, et al.
Journal of Neuro-Oncology|February 27, 2019
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastomaJingwen Yao, Caleb Hock Pang Tan, Jacob Schlossman, et al.
Neuro-Oncology|May 29, 2024
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumorsNicholas S Cho, Viên Lam Le, Francesco Sanvito, et al.
Neuroradiology|October 27, 2020
Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomasTalia C Oughourlian, Jingwen Yao, Akifumi Hagiwara, et al.
Molecular Imaging and Biology|December 4, 2014
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant GliomasElena Karavaeva, Robert J Harris, Kevin Leu, et al.
Journal of Neuro-Oncology|March 12, 2026
MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapyTerry J Prins, Thomas J Lai, Tie Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Voxelwise and Patientwise Correlation of <sup>18</sup>F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular SubtypesHiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, et al.
European Radiology|October 26, 2023
Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRIFrancesco Sanvito, Catalina Raymond, Nicholas S Cho, et al.
AJNR. American Journal of Neuroradiology|January 18, 2024
Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital SubtractionNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Neuroradiology|October 8, 2024
Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomasNicholas S Cho, Francesco Sanvito, Viên Lam Le, et al.
Pageof 21